BRAF and colorectal carcinoma: CIMP and global hypomethylation should be evaluated further in series stratified according to microsatellite-status, and simple markers, such as BRAF, which identify MSI and MSS CRC with high-level of methylation, the MSS ones clearly having a poor outcome [53,59].